Amphastar Pharmaceuticals Inc vs Iron Mountain Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.38 (market cap $826.08M), while Iron Mountain Inc trades at $122.4 (market cap $36.15B). The key difference: Iron Mountain Inc is far larger — about 43.8× Amphastar Pharmaceuticals Inc's market cap, and Iron Mountain Inc pays a 2.84% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | IRM | |
|---|---|---|
Market Cap | $826.08M | $36.15B |
Sector | Health | Real Estate |
52-Week High | $30.81 | $133.06 |
52-Week Low | $16.87 | $78.86 |
Enterprise Value | $1.22B | $55.29B |
Dividend Yield | — | 2.84% |
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →